2-methyl-5-ht has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reid, A; Sawynok, J | 1 |
| Ashby, CR; Jiang, LH; Kasser, RJ; Wang, RY | 1 |
2 other study(ies) available for 2-methyl-5-ht and oxidopamine
| Article | Year |
|---|---|
Noradrenergic and purinergic involvement in spinal antinociception by 5-hydroxytryptamine and 2-methyl-5-hydroxytryptamine.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Injections, Spinal; Male; Oxidopamine; Pain; Phentolamine; Prazosin; Purinergic Antagonists; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Purinergic; Serotonin; Spinal Cord; Theophylline; Yohimbine | 1991 |
The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study.
Topics: Animals; Dopamine; Electrochemistry; Hydroxydopamines; Injections, Intraventricular; Male; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Septal Nuclei; Serotonin | 1990 |